# CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs

> **NCT07701590** · NA · RECRUITING · sponsor: **Capsicure, LLC** · enrollment: 147 (estimated)

## Conditions studied

- Wound, Foot
- Diabetic Foot Ulcer (DFU)
- Venus Leg Ulcer

## Interventions

- **DEVICE:** Microlyte®
- **DEVICE:** IP 1: Membrane Wrap - Hydro

## Key facts

- **NCT ID:** NCT07701590
- **Lead sponsor:** Capsicure, LLC
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-22
- **Primary completion:** 2026-12-20
- **Final completion:** 2026-12-20
- **Target enrollment:** 147 (ESTIMATED)
- **Last updated:** 2026-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07701590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07701590, "CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07701590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*